Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature

被引:98
作者
Furuta, Saori [1 ]
Wang, Ju-Ming [1 ]
Wei, Shuanzeng [1 ]
Jeng, Yung-Ming [1 ]
Jiang, Xianzhi [1 ]
Gu, Bingnan [1 ]
Chen, Phang-Lang [1 ]
Lee, Eva Y. -H. P. [1 ]
Lee, Wen-Hwa [1 ]
机构
[1] Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA
关键词
D O I
10.1016/j.ccr.2006.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BRCA1 exerts transcriptional repression through interaction with CUP in the C-terminal BRCT domain and ZBRK1 in the central domain. A dozen genes, including angiopoietin-1 (ANG1), a secreted angiogenic factor, are corepressed by BRCA1 and CUP based on microarray analysis of mammary epithelial cells in 3D culture. BRCA1, CUP, and ZBRK1 form a complex that coordinately represses ANG1 expression via a ZBRK1 recognition site in the ANG1 promoter. Impairment of this complex upregulates ANG1, which stabilizes endothelial cells that form a capillary-like network structure. Consistently, Brca1-deficient mouse mammary tumors exhibit accelerated growth, pronounced vascularization, and overexpressed ANG1. These results suggest that, besides its role in maintaining genomic stability, BRCA1 directly regulates the expression of angiogenic factors to modulate the tumor microenvironment.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 47 条
[1]   ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation [J].
Brown, C ;
Gaspar, J ;
Pettit, A ;
Lee, R ;
Gu, XS ;
Wang, H ;
Manning, C ;
Voland, C ;
Goldring, SR ;
Goldring, MB ;
Libermann, TA ;
Gravallese, EM ;
Oettgen, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12794-12803
[2]   Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1 [J].
Caine, GJ ;
Blann, AD ;
Stonelake, PS ;
Ryan, P ;
Lip, GYH .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (10) :883-890
[3]   Inactivation of CtIP leads to early embryonic lethality mediated by G1 restraint and to tumorigenesis haploid insufficiency [J].
Chen, PL ;
Liu, F ;
Cai, SN ;
Lin, XQ ;
Li, AH ;
Chen, YM ;
Gu, BN ;
Lee, EYHP ;
Lee, WH .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (09) :3535-3542
[4]  
Chen YM, 1996, CANCER RES, V56, P3168
[5]   ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER [J].
CHEN, YM ;
CHEN, CF ;
RILEY, DJ ;
ALLRED, DC ;
CHEN, PL ;
VONHOFF, D ;
OSBORNE, CK ;
LEE, WH .
SCIENCE, 1995, 270 (5237) :789-791
[6]   CtIP, a candidate tumor susceptibility gene is a team player with luminaries [J].
Chinnadurai, G .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1765 (01) :67-73
[7]   BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer [J].
Couch, FJ ;
DeShano, ML ;
Blackwood, MA ;
Calzone, K ;
Stopfer, J ;
Campeau, L ;
Ganguly, A ;
Rebbeck, T ;
Weber, BL ;
Jablon, L ;
Cobleigh, MA ;
Hoskins, K ;
Garber, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) :1409-1415
[8]  
CULLMANN G, 1995, MOL CELL BIOL, V15, P4661
[9]   LIM kinase 1 is essential for the invasive growth of prostate epithelial cells - Implications in prostate cancer [J].
Davila, M ;
Frost, AR ;
Grizzle, WE ;
Chakrabarti, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36868-36875
[10]   Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures [J].
Debnath, J ;
Muthuswamy, SK ;
Brugge, JS .
METHODS, 2003, 30 (03) :256-268